TY - JOUR T1 - A potential harmful effect of dexamethasone in non-severe COVID-19: results from the COPPER-pilot study JF - ERJ Open Research JO - erjor DO - 10.1183/23120541.00129-2022 VL - 8 IS - 2 SP - 00129-2022 AU - Janwillem Kocks AU - Marjan Kerkhof AU - Jan Scherpenisse AU - Aimée van de Maat AU - Iris van Geer-Postmus AU - Thomas le Rütte AU - Jan Schaart AU - Reinold O.B. Gans AU - Huib A.M. Kerstjens Y1 - 2022/04/01 UR - http://openres.ersjournals.com/content/8/2/00129-2022.abstract N2 - The coronavirus disease 2019 (COVID-19) pandemic poses major challenges to healthcare professionals. General practitioners (GPs) are at the frontline and may play an important role in preventing progression to severe disease, and in countering shortages of hospital beds. However, guideline-based treatment options for COVID-19 are still limited for GPs [1].This study suggests caution when prescribing systemic corticosteroids to patients with #COVID19 who show mild-to-moderate pulmonary symptoms because a harmful effect cannot be excluded https://bit.ly/3P4nOjQ ER -